Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

2.

Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

Vega F, Medeiros LJ, Leventaki V, Atwell C, Cho-Vega JH, Tian L, Claret FX, Rassidakis GZ.

Cancer Res. 2006 Jul 1;66(13):6589-97.

3.

Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway.

Guo H, Zhou T, Jiang D, Cuconati A, Xiao GH, Block TM, Guo JT.

J Virol. 2007 Sep;81(18):10072-80. Epub 2007 Jul 3.

6.
7.
9.

Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells.

Parmar S, Smith J, Sassano A, Uddin S, Katsoulidis E, Majchrzak B, Kambhampati S, Eklund EA, Tallman MS, Fish EN, Platanias LC.

Blood. 2005 Oct 1;106(7):2436-43. Epub 2005 Mar 24.

10.
12.

ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells.

Fuchs BC, Finger RE, Onan MC, Bode BP.

Am J Physiol Cell Physiol. 2007 Jul;293(1):C55-63. Epub 2007 Feb 28.

14.

Insulin-induced mTOR activity exhibits anti-hepatitis C virus activity.

Muraoka T, Ichikawa T, Taura N, Miyaaki H, Takeshita S, Akiyama M, Miuma S, Ozawa E, Isomoto H, Takeshima F, Nakao K.

Mol Med Rep. 2012 Feb;5(2):331-5. doi: 10.3892/mmr.2011.662. Epub 2011 Nov 3.

PMID:
22052332
17.

Temporal activation of p70 S6 kinase and Akt1 by insulin: PI 3-kinase-dependent and -independent mechanisms.

Somwar R, Sumitani S, Taha C, Sweeney G, Klip A.

Am J Physiol. 1998 Oct;275(4 Pt 1):E618-25.

PMID:
9755080
18.

Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.

Marzec M, Kasprzycka M, Liu X, El-Salem M, Halasa K, Raghunath PN, Bucki R, Wlodarski P, Wasik MA.

Oncogene. 2007 Aug 16;26(38):5606-14. Epub 2007 Mar 12.

PMID:
17353907
20.

Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.

Ghosh PM, Malik SN, Bedolla RG, Wang Y, Mikhailova M, Prihoda TJ, Troyer DA, Kreisberg JI.

Endocr Relat Cancer. 2005 Mar;12(1):119-34.

PMID:
15788644

Supplemental Content

Support Center